» Articles » PMID: 38826084

Hyperactivation of MEK1 in Cortical Glutamatergic Neurons Results in Projection Axon Deficits and Aberrant Motor Learning

Overview
Journal Dis Model Mech
Specialty General Medicine
Date 2024 Jun 3
PMID 38826084
Authors
Affiliations
Soon will be listed here.
Abstract

Abnormal extracellular signal-regulated kinase 1/2 (ERK1/2, encoded by Mapk3 and Mapk1, respectively) signaling is linked to multiple neurodevelopmental diseases, especially the RASopathies, which typically exhibit ERK1/2 hyperactivation in neurons and non-neuronal cells. To better understand how excitatory neuron-autonomous ERK1/2 activity regulates forebrain development, we conditionally expressed a hyperactive MEK1 (MAP2K1) mutant, MEK1S217/221E, in cortical excitatory neurons of mice. MEK1S217/221E expression led to persistent hyperactivation of ERK1/2 in cortical axons, but not in soma/nuclei. We noted reduced axonal arborization in multiple target domains in mutant mice and reduced the levels of the activity-dependent protein ARC. These changes did not lead to deficits in voluntary locomotion or accelerating rotarod performance. However, skilled motor learning in a single-pellet retrieval task was significantly diminished in these MEK1S217/221E mutants. Restriction of MEK1S217/221E expression to layer V cortical neurons recapitulated axonal outgrowth deficits but did not affect motor learning. These results suggest that cortical excitatory neuron-autonomous hyperactivation of MEK1 is sufficient to drive deficits in axon outgrowth, which coincide with reduced ARC expression, and deficits in skilled motor learning. Our data indicate that neuron-autonomous decreases in long-range axonal outgrowth may be a key aspect of neuropathogenesis in RASopathies.

Citing Articles

Translating multiscale research in rare disease.

Hooper K, Justice M, Lek M, Liu K, Rauen K Dis Model Mech. 2024; 17(6).

PMID: 38982973 PMC: 11261626. DOI: 10.1242/dmm.052009.

References
1.
Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A . Activation of mitogen-activated protein kinases/extracellular signal-regulated kinases in human hepatocellular carcinoma. Hepatology. 1998; 27(4):951-8. DOI: 10.1002/hep.510270409. View

2.
Altmuller F, Pothula S, Annamneedi A, Nakhaei-Rad S, Montenegro-Venegas C, Pina-Fernandez E . Aberrant neuronal activity-induced signaling and gene expression in a mouse model of RASopathy. PLoS Genet. 2017; 13(3):e1006684. PMC: 5386306. DOI: 10.1371/journal.pgen.1006684. View

3.
Ishii A, Furusho M, Bansal R . Sustained activation of ERK1/2 MAPK in oligodendrocytes and schwann cells enhances myelin growth and stimulates oligodendrocyte progenitor expansion. J Neurosci. 2013; 33(1):175-86. PMC: 3711773. DOI: 10.1523/JNEUROSCI.4403-12.2013. View

4.
Newbern J, Li X, Shoemaker S, Zhou J, Zhong J, Wu Y . Specific functions for ERK/MAPK signaling during PNS development. Neuron. 2011; 69(1):91-105. PMC: 3060558. DOI: 10.1016/j.neuron.2010.12.003. View

5.
Zamboni S, Loenneker T, Boltshauser E, Martin E, Ilyasov K . Contribution of diffusion tensor MR imaging in detecting cerebral microstructural changes in adults with neurofibromatosis type 1. AJNR Am J Neuroradiol. 2007; 28(4):773-6. PMC: 7977343. View